WO2002039929A2 - Stent retaining hybrid sleeve material and structure - Google Patents

Stent retaining hybrid sleeve material and structure Download PDF

Info

Publication number
WO2002039929A2
WO2002039929A2 PCT/US2001/050707 US0150707W WO0239929A2 WO 2002039929 A2 WO2002039929 A2 WO 2002039929A2 US 0150707 W US0150707 W US 0150707W WO 0239929 A2 WO0239929 A2 WO 0239929A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
catheter
predetermined hardness
inside surface
sleeve
Prior art date
Application number
PCT/US2001/050707
Other languages
French (fr)
Other versions
WO2002039929A3 (en
Inventor
John J. Chen
Daniel J. Horn
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/716,757 external-priority patent/US6805702B1/en
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Priority to AU2002231320A priority Critical patent/AU2002231320A1/en
Priority to EP01991597A priority patent/EP1335682A2/en
Priority to CA002424061A priority patent/CA2424061A1/en
Priority to JP2002542306A priority patent/JP2004513703A/en
Publication of WO2002039929A2 publication Critical patent/WO2002039929A2/en
Publication of WO2002039929A3 publication Critical patent/WO2002039929A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0019Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in hardness, e.g. Vickers, Shore, Brinell

Definitions

  • This invention relates to medical device delivery catheters in general, and specifically to balloon catheters for use in delivering a medical device such as a stent to a desired body location, such as in a blood vessel. More specifically, this invention relates to socks or sleeves used in retaining the stent in the unexpanded state which have reduced frictional engagement with the ends of a stent and/or balloon cones. In the present invention such reduced frictional interaction is made possible by providing the sleeve or sleeves with an inside surface of which at least a portion is characterized as being harder than the outside surface.
  • Stents and stent delivery assemblies are utilized in a number of medical procedures and situations, and as such their structure and function are well known.
  • a stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter and then expanded to the diameter of the vessel. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition.
  • Both self-expanding and inflation expandable stents are well known and widely available in a variety of designs and configurations. Self-expanding stents must be maintained under positive external pressure in order to maintain their reduced diameter configuration during delivery of the stent to its deployment site.
  • Inflation expandable stents may be crimped to their reduced diameter about the delivery catheter, maneuvered to the deployment site, and expanded to the vessel diameter by fluid inflation of a balloon positioned on the delivery catheter.
  • the present invention is particularly concerned with delivery and deployment of inflation expandable stents, although it is generally applicable to self-expanding stents when used with balloon catheters.
  • the stent Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery.
  • the stent is expandable by means of the expandable balloon on the catheter. During expansion of the stent at the deployment site, the stent margins are freed of the protective sleeve(s).
  • U.S. Patent 5,403,341 to Solar relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent. The retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths.
  • U.S. Patent No. 5,108,416 to Ryan et al. describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site.
  • friction can occur between the guide catheter and guide wire, between the introducer sheath and the guide catheter, or between the guide catheter and the balloon catheter, for instance, and may increase the difficulty of insertion, cause loss of catheter placement, and result in discomfort to the patient or damage to the vasculature.
  • friction between the balloon and sleeve, and/or the stent and sleeve may also cause retraction of the sleeves to be made more difficult.
  • the relatively soft coating may increase its friction to the sock or sleeve system.
  • Lubricants however may be used in a variety of stent delivery catheters. Many lubricants and lubricious coatings types have been used in conjunction with balloon catheters. Both hydrophilic and hydrophobic coatings and lubricants are well known in the catheter art.
  • copending U.S. Patent Application No. 09/407,836 which was filed on September 28, 1999 and entitled Stent Securement Sleeves and Optional Coatings and Methods of Use, provides for a stent delivery system having sleeves.
  • the sleeves may be made up of a combination of polytetrafluoroethylene (hereinafter PTFE) as well as one or more thermoplastic elastomers.
  • PTFE polytetrafluoroethylene
  • Copending U.S. Patent Application No. 09/427,805 filed October 27, 1999, and entitled End Sleeve Coating for Stent Delivery describes the use of stent retaining sleeves having lubricious coatings applied thereto.
  • Stent delivery systems which may not require the use of lubricants have been proposed, such as copending U.S. Application No. 09/549,286 mentioned above.
  • Another example of a stent delivery system and retaining sleeve which may not require , lubrication is Copending application 09/668,496 filed September 22, 2000 and entitled Striped Sleeve For Stent Delivery describes a two component sleeve having one or more substantially longitudinally oriented stripe of a hard material and a softer material.
  • the striped configuration of materials in the sleeve allows the sleeve to radially expand but with limited or no longitudinal expansion.
  • the unique expansion characteristics provided by the striped configuration helps avoid a need to use a lubricant with the sleeve, though a lubricant may still be utilized therewith if desired.
  • the instant invention is directed to a medical device delivery system comprising a catheter assembly having a medical device receiving region and at least one retaining sleeve for retaining the medical device on the receiving region prior to delivery.
  • An expandable medical device such as a stent, is disposed about the medical device receiving region of the catheter assembly.
  • At least one retaining sleeve is disposed about an end of the expandable medical device and at least a portion of the catheter assembly.
  • the at least one retaining sleeve further comprises an inside surface and an outside surface.
  • the outside surface being comprised of a first material and at least the portion of the inside surface which is constructed to overlay a stent being comprised of a second material.
  • the first and second materials having different harnesses, the second material being harder than the first.
  • the hardness represents the capacity of elongation when the polymer is exposed to an outside acting force, this is especially true for elastomeric materials (e.g. the lower a material's hardness the higher the material's elasticity).
  • the present invention improves sleeve retractability by providing at least the portion of the inside surface of the sleeve which may overlay a stent with a material which has a greater hardness than the majority of the sleeve material.
  • a relatively hard material preferably provides the sleeve with a surface having lower frictional engagement to the stent.
  • first material and second material are co-extruded polymers.
  • second material is a coating on the first material.
  • the inside surface is comprised entirely of the second material.
  • only the portion of the inside surface which is constructed and arranged to overlay a stent is comprised of the harder material.
  • FIG. 1 is a side view of a first embodiment of the invention
  • FIG. 2 is a side view of a second embodiment of the invention
  • FIG. 3 is a side view of a third embodiment of the invention.
  • FIG. 4 is a side view of a forth embodiment of the invention.
  • the present invention may be embodied in a stent delivery catheter, indicated generally at 10.
  • Catheter 10 includes a stent mounting region 12, the stent mounting region 12 may be an inflatable portion of the catheter or may be a separate balloon mounted to the catheter shaft 14.
  • the balloon 12 may have an unexpanded state and an expanded state.
  • a stent 16, disposed about the stent mounting region 12 may be delivered when the balloon 12 is expanded to the expanded state.
  • the stent 16 includes a proximal end 18 and a distal end 20.
  • a stent retaining sleeve 22 overlies at least a portion of each end 18 and 20.
  • the ends of the stent retaining sleeves 22 are configured to retract off of the stent ends 18 and 20.
  • the sleeves 22 have a unique construction which provides the first portion 24 of the sleeve which overlies the stent 16, with a reduced frictional engagement with the stent 16 by providing the inside surface 100 of the first portion 24 with a material 34 which is harder than that of the outer surface 102 of the sleeve 22.
  • the second portion 26 of the sleeve 22 is disposed about and is engaged to a portion of the catheter shaft 14 adjacent to the balloon 12.
  • the present invention ensures that the stent is delivered with improved sleeve retractability.
  • the sleeves 22 are constructed from at least two materials having different hardness characteristics.
  • the first material 30 is formed into a generally tubular body 32 which provides the sleeve with its shape as well as its outer surface 102. At least a portion of the first end 24 of the inside surface 100 is composed of the second material 34. 5
  • the first material 30 may be any elastic material known which has a hardness as measured by a Shore durometer of less than 55D. Preferably the durometer hardness of the first material is between 40A and 100A.
  • the second material 34 may be any material having a durometer hardness greater than about 55D. In at least one embodiment of the invention the first material 30 has a hardness of 35D and the second
  • 10 material 34 has a hardness of 70D.
  • the first material 30 may be selected from one or more of the following substances: soft grade polyester/poly ether elastomers such as ArnitelTM available from DSM Engineering, polyurethane-polyether polymers, such as TecothaneTM 1074A available from Thermedics, Inc.; polyester-polyurethanes, such as PellethaneTM 2102-
  • soft grade polyester/poly ether elastomers such as ArnitelTM available from DSM Engineering, polyurethane-polyether polymers, such as TecothaneTM 1074A available from Thermedics, Inc.
  • polyester-polyurethanes such as PellethaneTM 2102-
  • polyester-polyurethanes such as EstaneTM 5703P sold by BF Goodrich
  • polyether block amides such as PebaxTM 2533 available from Elf Atochem
  • styrene-butadien-styrene triblock copolymers such as KratonTM Dl 101 sold by Shell Chemical company.
  • Other materials which may also be used in the production of the first material 30 include, but are not limited to styrenic block
  • copolymers polyurethanes, silicone rubber, natural rubber, copolyesters, polyamides, EPDM rubber/polyolefin, nitril rubber/PVC, fluoroelastomers, butyl rubber, epichlorohydrin, soft block copolymers, and any combinations thereof.
  • the second material 34 may be selected from one or more of the following substances: polyethyleneterephthalate (PET), polybutylene terephthalate
  • polytrimethylene terephthalate (PTT),NylonTM engineering thermoplastic polyurethanes, fluoropolymers, polyester/polyether elastomers such as ArnitelTM available from DSM Engineering, polyurethane-polyether polymers, such as TecothaneTM 1055D or 1075D both of which are available from Thermedics, Inc.; polyester-polyurethanes, such as EstaneTM 58170 sold by BF Goodrich; polyether block
  • amides such as PebaxTM 7233 or 6333 both of which are available from Elf Atochem.
  • Other materials which may also be used in the production of the second material 34 include, but are not limited to: polyolefins, polystyrene, polyvinyl chloride, acrylonitrile- butadiene-styrene polymers, polyacrylonitrile, polyacrylate, vinyl acetate polymer, cellulose plastics, polyurethanes, polyethylene terephthalate, polyacetal, polyethers, polycarbonates, polyamides, polyphenylene sulfide, polyarylethersulfones, 5 polyaryletherketones, polytetrafluoroethylene, and any combinations thereof.
  • first and second materials 30 and 34 are in no way exhaustive of the potential substances or combinations of substances which may be used.
  • the present invention is directed to a sleeve composed of any materials which have the hardness qualities previously described for the respective materials 30 and 34.
  • the present invention may be embodied in a variety of manners.
  • the catheter 10 is seen with a pair of sleeves 22 each of which have a first portion 24 with an inner surface 100 which is composed of a second material 34, such as is described above.
  • Second material 34 may be a coating of hardened material applied to the inside surface
  • the material 34 may be bonded or welded to the sleeve 22, or first material 30 and second material 34 may have been co-extruded together in the form of sleeve 22 shown.
  • Other methods for joining the materials 30 and 34, such as selective coating by printing, may also be utilized.
  • the entire inside surface 100 of the sleeve(s) 22 0 may be composed of the second material 34.
  • FIGs. 3 and 4 show the sleeve configurations respectfully described in relation to FIGs. 1 and 2 as they may be embodied on a sleeve 22 exclusive of the stent delivery catheter 10.
  • a retractable sheath (not shown) such as are known in the art, may be employed to overlay the stent.
  • a single sleeve or two sleeves such have been shown and described may be employed to retain the self- expanding stent in place.
  • the sheath When the sheath is retracted the stent will expand causing the sleeve(s) to retract.

Abstract

A stent delivery system comprising a catheter including a stent mounting region. A stent disposed about the stent mounting region of the catheter, the stent having a distal end and a proximal end, the stent further having an unexpanded state and an expanded state. At least one stent retaining sleeve having a first end overlying an end of the stent when the stent is in the unexpanded state, a second end engaged to at least a portion of the catheter adjacent to the stent mounting region. The outside surface of the stent retaining sleeve being composed of a first material, at least a portion of the first end of the inside surface being composed of a second material. The first material having a first predetermined hardness, the second material having a second predetermined hardness, the second predetermined hardness having a higher durometer value than the first predetermined hardness.

Description

TITLE
Hybrid Sleeve Material and Structure
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a Continuation-In-Part application from US
Application No. 09/668,496, filed September 22, 2000, the entire contents of which is hereby incorporated by reference.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH Not Applicable
BACKGROUND OF THE INVENTION Field of The Invention
This invention relates to medical device delivery catheters in general, and specifically to balloon catheters for use in delivering a medical device such as a stent to a desired body location, such as in a blood vessel. More specifically, this invention relates to socks or sleeves used in retaining the stent in the unexpanded state which have reduced frictional engagement with the ends of a stent and/or balloon cones. In the present invention such reduced frictional interaction is made possible by providing the sleeve or sleeves with an inside surface of which at least a portion is characterized as being harder than the outside surface.
Description Of The Related Art:
Stents and stent delivery assemblies are utilized in a number of medical procedures and situations, and as such their structure and function are well known. A stent is a generally cylindrical prosthesis introduced via a catheter into a lumen of a body vessel in a configuration having a generally reduced diameter and then expanded to the diameter of the vessel. In its expanded configuration, the stent supports and reinforces the vessel walls while maintaining the vessel in an open, unobstructed condition. Both self-expanding and inflation expandable stents are well known and widely available in a variety of designs and configurations. Self-expanding stents must be maintained under positive external pressure in order to maintain their reduced diameter configuration during delivery of the stent to its deployment site. Inflation expandable stents may be crimped to their reduced diameter about the delivery catheter, maneuvered to the deployment site, and expanded to the vessel diameter by fluid inflation of a balloon positioned on the delivery catheter. The present invention is particularly concerned with delivery and deployment of inflation expandable stents, although it is generally applicable to self-expanding stents when used with balloon catheters.
In advancing an inflation expandable stent through a body vessel to the deployment site, there are a number of important considerations. The stent must be able to securely maintain its axial position on the delivery catheter, without translocating proximally or distally, and especially without becoming separated from the catheter. The stent, particularly its distal and proximal ends, must be protected to prevent distortion of the stent and to prevent abrasion and/or reduce trauma of the vessel walls. Inflation expandable stent delivery and deployment assemblies are known which utilize restraining means that overlie the stent during delivery. U.S. Patent No. 4,950,227 to Savin et al, relates to an expandable stent delivery system in which a sleeve overlaps the distal or proximal margin (or both) of the stent during delivery. That patent discloses a stent delivery system in which a catheter carries, on its distal end portion, a stent which is held in place around the catheter prior to and during percutaneous delivery by means of one and preferably two sleeves. The sleeves are positioned around the catheter with one end portion attached thereto and overlap an end portion(s) of the stent to hold it in place on the catheter in a contracted condition. Each sleeve is elastomeric in nature so as to stretch and release the stent when it expands for implantation. The stent is expandable by means of the expandable balloon on the catheter. During expansion of the stent at the deployment site, the stent margins are freed of the protective sleeve(s). U.S. Patent 5,403,341 to Solar, relates to a stent delivery and deployment assembly which uses retaining sheaths positioned about opposite ends of the compressed stent. The retaining sheaths of Solar are adapted to tear under pressure as the stent is radially expanded, thus releasing the stent from engagement with the sheaths. U.S. Patent No. 5,108,416 to Ryan et al., describes a stent introducer system which uses one or two flexible end caps and an annular socket surrounding the balloon to position the stent during introduction to the deployment site.
Copending U.S. Patent Application No. 09/407,836 which was filed on September 28, 1999 and entitled Stent Securement Sleeves and Optional Coatings and Methods of Use, and which is incorporated in its entirety herein by reference, also provides for a stent delivery system having sleeves. In 09/407,836 the sleeves may be made up of a combination of polytetrafluoroethylene (PTFE) as well as one or more thermoplastic elastomers. Other references exist which disclose a variety of stent retaining sleeves. A common problem which occurs in catheter assemblies is friction or adhesion between various parts which periodically come into contact with one another during the medical procedure. For instance, friction can occur between the guide catheter and guide wire, between the introducer sheath and the guide catheter, or between the guide catheter and the balloon catheter, for instance, and may increase the difficulty of insertion, cause loss of catheter placement, and result in discomfort to the patient or damage to the vasculature. In catheters equipped with stent retaining socks or sleeves, friction between the balloon and sleeve, and/or the stent and sleeve may also cause retraction of the sleeves to be made more difficult. In stent delivery systems where the stent employs a relatively soft coating material on it surface, such as a drug carrier, the relatively soft coating may increase its friction to the sock or sleeve system. An example of which may be seen in U.S. Patent No. 5,693,085 to Buirge et al., the entire contents of which is incorporated herein by reference.
It is therefore desirable to reduce the friction due to the sliding between the various parts of the catheter assemblies. Copending U.S. Application No. 09/549,286 which was filed April 14, 2000 describes a reduced columnar strength stent retaining sleeve having a plurality of holes. The relatively reduced columnar and radial strength provided by the holes allows the sleeve to be retracted off of a stent without the need for lubricant.
Lubricants however may be used in a variety of stent delivery catheters. Many lubricants and lubricious coatings types have been used in conjunction with balloon catheters. Both hydrophilic and hydrophobic coatings and lubricants are well known in the catheter art. For example: copending U.S. Patent Application No. 09/407,836 which was filed on September 28, 1999 and entitled Stent Securement Sleeves and Optional Coatings and Methods of Use, provides for a stent delivery system having sleeves. In 09/407,836 the sleeves may be made up of a combination of polytetrafluoroethylene (hereinafter PTFE) as well as one or more thermoplastic elastomers. Copending U.S. Patent Application No. 09/427,805 filed October 27, 1999, and entitled End Sleeve Coating for Stent Delivery, describes the use of stent retaining sleeves having lubricious coatings applied thereto.
Copending U.S. Patent Application No. 09/273,520 filed March 22, 1999, entitled Lubricated Sleeve Material For Stent Delivery likewise describes the use of stent retaining sleeves and lubricants.
Stent delivery systems which may not require the use of lubricants have been proposed, such as copending U.S. Application No. 09/549,286 mentioned above. Another example of a stent delivery system and retaining sleeve which may not require , lubrication is Copending application 09/668,496 filed September 22, 2000 and entitled Striped Sleeve For Stent Delivery describes a two component sleeve having one or more substantially longitudinally oriented stripe of a hard material and a softer material. The striped configuration of materials in the sleeve allows the sleeve to radially expand but with limited or no longitudinal expansion. The unique expansion characteristics provided by the striped configuration helps avoid a need to use a lubricant with the sleeve, though a lubricant may still be utilized therewith if desired.
The entire content of all patents and applications listed within the present patent application are incorporated herein by reference.
BRIEF SUMMARY OF THE INVENTION
The instant invention is directed to a medical device delivery system comprising a catheter assembly having a medical device receiving region and at least one retaining sleeve for retaining the medical device on the receiving region prior to delivery. An expandable medical device, such as a stent, is disposed about the medical device receiving region of the catheter assembly. At least one retaining sleeve is disposed about an end of the expandable medical device and at least a portion of the catheter assembly.
The at least one retaining sleeve further comprises an inside surface and an outside surface. The outside surface being comprised of a first material and at least the portion of the inside surface which is constructed to overlay a stent being comprised of a second material. The first and second materials having different harnesses, the second material being harder than the first. As is known, for most polymer materials, the hardness represents the capacity of elongation when the polymer is exposed to an outside acting force, this is especially true for elastomeric materials (e.g. the lower a material's hardness the higher the material's elasticity).
Unlike the 09/668,496 application, from which the present application depends, and which provides for a sleeve having reduced longitudinal elongation, the present invention improves sleeve retractability by providing at least the portion of the inside surface of the sleeve which may overlay a stent with a material which has a greater hardness than the majority of the sleeve material. Such a relatively hard material preferably provides the sleeve with a surface having lower frictional engagement to the stent.
In an embodiment of the invention the first material and second material are co-extruded polymers. In an embodiment of the invention the second material is a coating on the first material.
In an embodiment of the invention the inside surface is comprised entirely of the second material.
In an embodiment of the invention only the portion of the inside surface which is constructed and arranged to overlay a stent is comprised of the harder material.
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
A detailed description of the invention is hereafter described with specific reference being made to the drawings in which:
FIG. 1 is a side view of a first embodiment of the invention; FIG. 2 is a side view of a second embodiment of the invention;
FIG. 3 is a side view of a third embodiment of the invention; and FIG. 4 is a side view of a forth embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION As may be seen in FIG. 1 , the present invention may be embodied in a stent delivery catheter, indicated generally at 10. Catheter 10, includes a stent mounting region 12, the stent mounting region 12 may be an inflatable portion of the catheter or may be a separate balloon mounted to the catheter shaft 14. The balloon 12 may have an unexpanded state and an expanded state. A stent 16, disposed about the stent mounting region 12 may be delivered when the balloon 12 is expanded to the expanded state. The stent 16 includes a proximal end 18 and a distal end 20. In the embodiment shown a stent retaining sleeve 22 overlies at least a portion of each end 18 and 20. As is known in the art, when the balloon 12 and stent 16 are expanded to their expanded state, the ends of the stent retaining sleeves 22 are configured to retract off of the stent ends 18 and 20. In the present invention, the sleeves 22 have a unique construction which provides the first portion 24 of the sleeve which overlies the stent 16, with a reduced frictional engagement with the stent 16 by providing the inside surface 100 of the first portion 24 with a material 34 which is harder than that of the outer surface 102 of the sleeve 22. The second portion 26 of the sleeve 22 is disposed about and is engaged to a portion of the catheter shaft 14 adjacent to the balloon 12.
As stent 16 is expanded, the stent ends 18 and 20 will eventually be drawn from underneath the stent retaining sleeves 22. By providing a sleeve 22 which has a reduced frictional engagement with the stent ends 18 and 20 the present invention ensures that the stent is delivered with improved sleeve retractability.
As previously indicated, the sleeves 22 are constructed from at least two materials having different hardness characteristics. The first material 30 is formed into a generally tubular body 32 which provides the sleeve with its shape as well as its outer surface 102. At least a portion of the first end 24 of the inside surface 100 is composed of the second material 34. 5 The first material 30 may be any elastic material known which has a hardness as measured by a Shore durometer of less than 55D. Preferably the durometer hardness of the first material is between 40A and 100A. The second material 34 may be any material having a durometer hardness greater than about 55D. In at least one embodiment of the invention the first material 30 has a hardness of 35D and the second
10 material 34 has a hardness of 70D.
The first material 30 may be selected from one or more of the following substances: soft grade polyester/poly ether elastomers such as Arnitel™ available from DSM Engineering, polyurethane-polyether polymers, such as Tecothane™ 1074A available from Thermedics, Inc.; polyester-polyurethanes, such as Pellethane™ 2102-
15 75 A sold by Dow Chemical; polyester-polyurethanes, such as Estane™ 5703P sold by BF Goodrich; polyether block amides, such as Pebax™ 2533 available from Elf Atochem; and styrene-butadien-styrene triblock copolymers such as Kraton™ Dl 101 sold by Shell Chemical company. Other materials which may also be used in the production of the first material 30 include, but are not limited to styrenic block
20 copolymers, polyurethanes, silicone rubber, natural rubber, copolyesters, polyamides, EPDM rubber/polyolefin, nitril rubber/PVC, fluoroelastomers, butyl rubber, epichlorohydrin, soft block copolymers, and any combinations thereof.
The second material 34 may be selected from one or more of the following substances: polyethyleneterephthalate (PET), polybutylene terephthalate
25 (PBT), polytrimethylene terephthalate (PTT),Nylon™, engineering thermoplastic polyurethanes, fluoropolymers, polyester/polyether elastomers such as Arnitel™ available from DSM Engineering, polyurethane-polyether polymers, such as Tecothane™ 1055D or 1075D both of which are available from Thermedics, Inc.; polyester-polyurethanes, such as Estane™ 58170 sold by BF Goodrich; polyether block
30 amides, such as Pebax™ 7233 or 6333 both of which are available from Elf Atochem. Other materials which may also be used in the production of the second material 34 include, but are not limited to: polyolefins, polystyrene, polyvinyl chloride, acrylonitrile- butadiene-styrene polymers, polyacrylonitrile, polyacrylate, vinyl acetate polymer, cellulose plastics, polyurethanes, polyethylene terephthalate, polyacetal, polyethers, polycarbonates, polyamides, polyphenylene sulfide, polyarylethersulfones, 5 polyaryletherketones, polytetrafluoroethylene, and any combinations thereof.
The above examples of the first and second materials 30 and 34 are in no way exhaustive of the potential substances or combinations of substances which may be used. The present invention is directed to a sleeve composed of any materials which have the hardness qualities previously described for the respective materials 30 and 34.
10 As may be seen in the various figures, the present invention may be embodied in a variety of manners. For instance, in the embodiment shown in FIG. 1 the catheter 10 is seen with a pair of sleeves 22 each of which have a first portion 24 with an inner surface 100 which is composed of a second material 34, such as is described above. Second material 34 may be a coating of hardened material applied to the inside surface
15 100 of the sleeve 22. Alternatively, the material 34 may be bonded or welded to the sleeve 22, or first material 30 and second material 34 may have been co-extruded together in the form of sleeve 22 shown. Other methods for joining the materials 30 and 34, such as selective coating by printing, may also be utilized.
As may be seen in FIG. 2, the entire inside surface 100 of the sleeve(s) 22 0 may be composed of the second material 34.
FIGs. 3 and 4 show the sleeve configurations respectfully described in relation to FIGs. 1 and 2 as they may be embodied on a sleeve 22 exclusive of the stent delivery catheter 10.
In alternative embodiments, notably those utilized specifically for delivery 5 of a self expanding stent, a retractable sheath (not shown) such as are known in the art, may be employed to overlay the stent. In such embodiments a single sleeve or two sleeves such have been shown and described may be employed to retain the self- expanding stent in place. When the sheath is retracted the stent will expand causing the sleeve(s) to retract.
30 In addition to being directed to the embodiments described above and claimed below, the present invention is further directed to embodiments having different combinations of the features described above and claimed below. As such, the invention is also directed to other embodiments having any other possible combination of the dependent features claimed below.
The above examples and disclosure are intended to be illustrative and not exhaustive. These examples and description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.

Claims

1. A stent delivery system comprising: a catheter including a stent mounting region; a stent disposed about the stent mounting region of the catheter, the stent having a distal end and a proximal end, the stent further having an unexpanded state and an expanded state, and at least one stent retaining sleeve, the at least one stent retaining sleeve having an inside surface and an outside surface and a first end and a second end, the first end overlying an end of the stent when the stent is in the unexpanded state, the second end engaged to at least a portion of the catheter adjacent to the stent mounting region; the outside surface being composed of a first material, at least a portion of the first end of the inside surface being composed of a second material; the first material having a first predetermined hardness, the second material having a second predetermined hardness, the second predetermined hardness having a higher durometer value than the first predetermined hardness.
2. The stent delivery catheter of claim 1 wherein the second material is relatively smoother than the first material.
3. The stent delivery catheter of claim 1 where in the first predetermined hardness is less than approximately 55D, and the second predetermined hardness is least 55D.
4. The stent delivery catheter of claim 1 where in the first predetermined hardness is approximately 35D, and the second predetermined hardness is approximately 55D.
5. The stent delivery catheter of claim 1 wherein the inside surface is comprised of the second material.
6. The stent delivery catheter of claim 1 wherein the first material and the second material are co-extruded.
7. The stent delivery catheter of claim 1 wherein the second material is a coating, the coating being applied to at least the first end of the inside surface of the at least one
5 stent retaining sleeve.
8. The stent delivery system of claim 7 wherein the coating is selected from at least one member of the group consisting of: polyolefins, polystyrene, polyvinyl chloride, acrylonitrile-butadiene-styrene polymers, polyacrylonitrile, polyacrylate, vinyl acetate
10 polymer, cellulose plastics, polyurethanes, polyethylene terephthalate, polyacetal, polyethers, polycarbonates, polyamides, polyphenylene sulfide, polyarylethersulfones, polyaryletherketones, polytetrafluoroethylene, and any combinations thereof.
9. The stent delivery system of claim 1 wherein the first material is constructed from 15 at least one member of the group consisting of: styrenic block copolymers, polyurethanes, silicone rubber, natural rubber, copolyesters, polyamides, EPDM rubber/polyolefin, nitril rubber/PVC, fluoroelastomers, butyl rubber, epichlorohydrin, polyester elastomers, polyamide elastomers and any combinations thereof.
20 10. The stent delivery system of claim 1 wherein the second material is constructed from at least one member of the group consisting of: polyolefins, polystyrene, polyvinyl chloride, acrylonitrile-butadiene-styrene polymers, polyacrylonitrile, polyacrylate, vinyl acetate polymer, cellulose plastics, polyurethanes, polyethylene terephthalate, polyacetal, polyethers, polycarbonates, polyamides, polyphenylene sulfide, polyarylethersulfones,
25 polyaryletherketones, polytetrafluoroethylene, and any combinations thereof.
11. A stent retaining sleeve for retaining stent ends on a balloon catheter comprising: a first material and a second material, wherein the first material has a first predetermined hardness and the second material has a second predetermined hardness, 30 the second predetermined hardness being greater than the first predetermined hardness; the stent retaining sleeve having an inside surface and an outside surface, and a first end and a second end, the inside surface of the first end constructed and arranged to overlay an end of a stent, the second end constructed and arranged to be in contact with at least a portion of a catheter; at least a portion of the inside surface of the first end being composed of the second material.
12. A stent delivery system comprising: a catheter including a stent mounting region; a stent disposed about the stent mounting region of the catheter, the stent having a distal end and a proximal end, the stent further having an unexpanded state and an expanded state, and at least one stent retaining sleeve, the at least one stent retaining sleeve having a first end and a second end, the first end overlying an end of the stent when the stent is in the unexpanded state, the second end engaged to at least a portion of the catheter adjacent to the stent mounting region; the at least one sleeve having an inside surface and an outside surface, at least a portion of the inside surface characterized as being harder than the outside surface.
PCT/US2001/050707 2000-11-20 2001-10-24 Stent retaining hybrid sleeve material and structure WO2002039929A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002231320A AU2002231320A1 (en) 2000-11-20 2001-10-24 Stent retaining hybrid sleeve material and structure
EP01991597A EP1335682A2 (en) 2000-11-20 2001-10-24 Stent retaining hybrid sleeve material and structure
CA002424061A CA2424061A1 (en) 2000-11-20 2001-10-24 Stent retaining hybrid sleeve material and structure
JP2002542306A JP2004513703A (en) 2000-11-20 2001-10-24 Hybrid sleeve materials and configurations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/716,757 2000-11-20
US09/716,757 US6805702B1 (en) 2000-09-22 2000-11-20 Hybrid sleeve material and structure

Publications (2)

Publication Number Publication Date
WO2002039929A2 true WO2002039929A2 (en) 2002-05-23
WO2002039929A3 WO2002039929A3 (en) 2002-11-28

Family

ID=24879309

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/050707 WO2002039929A2 (en) 2000-11-20 2001-10-24 Stent retaining hybrid sleeve material and structure

Country Status (5)

Country Link
EP (1) EP1335682A2 (en)
JP (1) JP2004513703A (en)
AU (1) AU2002231320A1 (en)
CA (1) CA2424061A1 (en)
WO (1) WO2002039929A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080097512A1 (en) * 2004-11-18 2008-04-24 Sidwell Scott B Complex Medical Balloons

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068634A (en) * 1996-08-23 2000-05-30 Scimed Life Systems, Inc. Stent delivery system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068634A (en) * 1996-08-23 2000-05-30 Scimed Life Systems, Inc. Stent delivery system

Also Published As

Publication number Publication date
JP2004513703A (en) 2004-05-13
WO2002039929A3 (en) 2002-11-28
CA2424061A1 (en) 2002-05-23
EP1335682A2 (en) 2003-08-20
AU2002231320A1 (en) 2002-05-27

Similar Documents

Publication Publication Date Title
US6805702B1 (en) Hybrid sleeve material and structure
US6733520B2 (en) Sandwich striped sleeve for stent delivery
EP1349516B1 (en) Lubricant filler port for stent delivery system
EP1318771B1 (en) Two component sleeves for retaining stent ends on a balloon catheter
EP1113763B1 (en) Lubricated sleeve material for stent delivery
US20010000801A1 (en) Hydrophilic sleeve
US6607552B1 (en) Rolling socks
US7001419B2 (en) Stent delivery system with membrane
US20170100270A1 (en) Sleeves for positioning a stent on a delivery balloon catheter system
WO2001022903A2 (en) Stent securement sleeves with optional coatings and methods of use
EP1272126A1 (en) Stent securement system
US20080172120A1 (en) Endoprosthesis delivery systems and related methods
EP1343556B1 (en) Catheter for controlled stent delivery
WO2002039929A2 (en) Stent retaining hybrid sleeve material and structure

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2424061

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002542306

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001991597

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001991597

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001991597

Country of ref document: EP